enGene Holdings Inc (ENGN)
12.72
-1.47
(-10.36%)
USD |
NASDAQ |
May 20, 10:42
enGene Holdings Total Assets (Quarterly): 93.42M for Jan. 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | 93.42M |
| October 31, 2023 | 86.96M |
| July 31, 2023 | 46.28M |
| Date | Value |
|---|---|
| April 30, 2023 | 23.13M |
| October 31, 2022 | 23.91M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
23.13M
Minimum
Apr 2023
93.42M
Maximum
Jan 2024
54.74M
Average
46.28M
Median
Jul 2023
Total Assets (Quarterly) Benchmarks
| Acasti Pharma Inc | 76.18M |
| Aurinia Pharmaceuticals Inc | 548.06M |
| Edesa Biotech Inc | 6.475M |
| Lexaria Bioscience Corp | 6.352M |
| InMed Pharmaceuticals Inc | 13.36M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 31.04M |
| Shareholders Equity (Quarterly) | 62.38M |